January 19, 2017 10:47 AM ESTUpdated 01:38 PM
People

GSK R&D vet Rus­so jumps to Genen­ta, takes a lead role in de­vel­op­ing a new gene ther­a­py

John Carroll

Editor & Founder

GSK vet Car­lo Rus­so is join­ing up with some of his for­mer gene ther­a­py col­leagues, tak­ing the chief med­ical of­fi­cer’s role at Mi­lan-based Genen­ta …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Bris­tol My­er­s' TYK2 in­hibitor suc­ceeds in pair of Phase 3 pso­ri­at­ic arthri­tis tri­als

A service from the Financial Times